Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02989935

RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD

Status
Active Not Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study examines the effect of the ultra long acting beta agonist/corticosteroid bronchodilator combination fluticasone furoate/vilanterol trifenatate, on respiratory muscles and ventilation in adults with severe bronchitis or emphysema (COPD).

Detailed description

In adults with severe, minimally reversible bronchitis or emphysema (COPD), there is progressive hyperinflation of the lungs with associated flattening and inefficiency of the major respiratory muscle, the diaphragm. These changes limit physical activity and exercise, and provoke shortness of breath - dyspnea. These debilitating symptoms are often significantly lessened with ultra long acting combination bronchodilators, even in adults where the bronchodilator does not produce any measurable improvement in either airflow or lung hyperinflation. This symptomatic improvement in adults with severe, minimally reversible COPD may occur because of a direct benefit of the bronchodilator on respiratory muscles and ventilation. This study examines the effect of the ultra long acting bronchodilator fluticasone furoate/vilanterol trifenatate upon the upper anterior chest wall respiratory muscles (parasternals), the diaphragm, and breathing pattern.

Conditions

Interventions

TypeNameDescription
PROCEDUREVentilationMeasurements of ventilation with subjects seated, and breathing across a pneumotachygraph and pressure transducer to measure inspiratory airflow, during both resting and CO2 stimulated breathing.
PROCEDUREParasternal EMGRecordings of electrical activity (EMG) from the parasternal intercostal muscle in the second intercostal space on the upper anterior chest wall adjacent to the sternum.
PROCEDUREPhrenic magnetic stimulationBilateral maximal magnetic stimulation (Magstim) of the phrenic nerves.

Timeline

Start date
2016-04-01
Primary completion
2026-03-31
Completion
2026-07-01
First posted
2016-12-12
Last updated
2025-02-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02989935. Inclusion in this directory is not an endorsement.